Mo Li
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 4
- DNA Repair Mechanisms 3
- Metabolomics and Mass Spectrometry Studies 3
- CRISPR and Genetic Engineering 2
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Co-authors
- Hongyan Guo (3 shared papers)Yinan Xiao (2 shared papers)Bingteng Xie (8 shared papers)Jihong Ma (5 shared papers)Yuan Zhuang (1 shared paper)Chengqi Yi (2 shared papers)Jinghui Song (2 shared papers)Haowei Meng (1 shared paper)
- Journals
- Cell Biology International (3 papers)EBioMedicine (3 papers)iScience (1 paper)Biotechnology and Bioengineering (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Mo Li
29 papers receiving 712 citations
Mo Li's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 207
- Molecular Biology 500
- Business and International Management 14
- Aging 11
- Reproductive Medicine 30
Countries citing papers authored by Mo Li
This map shows the geographic impact of Mo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Li more than expected).
Fields of papers citing papers by Mo Li
This network shows the impact of papers produced by Mo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Li. The network helps show where Mo Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis Hit paper breakdown → | 2024 | 134 |
| 2 | 2022 | 126 | |
| 3 | 2019 | 89 | |
| 4 | 2020 | 78 | |
| 5 | 2021 | 40 | |
| 6 | 2021 | 36 | |
| 7 | 2023 | 22 | |
| 8 | 2017 | 20 | |
| 9 | 2022 | 20 | |
| 10 | 2021 | 18 | |
| 11 | 2023 | 18 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 14 | |
| 14 | 2022 | 11 | |
| 15 | 2024 | 10 | |
| 16 | 2020 | 9 | |
| 17 | 2023 | 9 | |
| 18 | 2021 | 8 | |
| 19 | 2020 | 8 | |
| 20 | 2023 | 5 |
About Mo Li
Mo Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Genetics, having authored 31 papers that have together received 717 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (4 papers), DNA Repair Mechanisms (3 papers), PARP inhibition in cancer therapy (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Cancer Research (207 citations), Molecular Biology (500 citations), Business and International Management (14 citations), Aging (11 citations) and Reproductive Medicine (30 citations). Mo Li has collaborated with scholars based in China, United States and India. Frequent co-authors include Hongyan Guo, Yinan Xiao, Bingteng Xie, Jihong Ma, Yuan Zhuang, Chengqi Yi, Jinghui Song, Haowei Meng, Chenxu Zhu and Bo Lu. Their work appears in journals such as Cell Biology International, EBioMedicine, iScience, Biotechnology and Bioengineering and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.